Note:
This article was written by a guest contributor from our community. The views and clinical opinions expressed here belong to the author and do not necessarily reflect the opinions or endorsements of Dr Tim Ltd.
Dr Tim Pearce
Nurse Practitioner, skinByJudeJude is a prescribing aesthetics nurse practitioner with a strong interest in menopausal skin health and regenerative treatments. Her focus is on achieving natural results through evidence-based practice using the highest quality product
One of the greatest misconceptions in aesthetic medicine is that facial symmetry is the norm. In reality, perfect facial symmetry is exceptionally uncommon. Almost every patient presents with some degree of asymmetry, whether skeletal, muscular, soft tissue or a combination of all three. Most asymmetries go unnoticed until treatment is contemplated, at which point patients often become acutely aware of differences they have never previously observed.
For the aesthetic practitioner, asymmetry presents both a diagnostic challenge and a communication challenge. Patients frequently describe concerns such as:
The temptation is to treat the side that appears “wrong”. However, successful treatment requires a different mindset. Rather than treating appearances, practitioners must identify the muscles responsible for the movement imbalance.
This principle underpins every successful asymmetry assessment:
Treat the muscle that is producing excessive movement – not simply the side that appears asymmetric.
Failure to identify the true source of asymmetry risks worsening the imbalance, creating new functional issues, or leaving the patient disappointed despite technically successful injections.
Before considering treatment, it is essential to understand that asymmetry is a normal characteristic of the human face.
Numerous factors contribute to differences between the two sides of the face, including:
As practitioners, we should normalise this during consultation. Aesthetic treatment aims to reduce distracting asymmetry rather than create mathematical symmetry.
Attempting to create perfect symmetry is rarely achievable and may produce an unnatural appearance.
One of the first steps during assessment is determining whether the asymmetry is static, dynamic, or a combination of both.
Static asymmetry is visible when the face is completely relaxed.
Common causes include:
Botulinum toxin has a limited role in correcting purely static asymmetry because there is no abnormal movement to modify.
In these patients, treatment may require alternative approaches such as volume restoration, skin tightening, surgical intervention, or simply reassurance.
Dynamic asymmetry only becomes apparent during movement.
Patients may demonstrate asymmetry when:
These are often the patients most suited to treatment with botulinum toxin because the imbalance results from unequal muscle activity rather than structural differences.
The goal is not to weaken an entire side of the face, but to selectively reduce overactivity within specific muscles to allow more balanced movement.
Dynamic asymmetry may result from several mechanisms.
Most healthy individuals have naturally unequal muscle strength.
Examples include:
These differences are physiological rather than pathological.
Repeated facial expressions over many years can create asymmetrical muscle dominance.
Examples include:
These patients often have no underlying neurological pathology.
Compensatory movement is one of the most important concepts in facial assessment.
When one muscle is relatively weak, antagonists or contralateral muscles frequently increase their activity to achieve the desired facial movement.
The consequence is that the side displaying the greatest movement is not always the “normal” side.
This becomes particularly important following facial nerve injury.
Although most asymmetries encountered in aesthetic practice are benign, practitioners must remain vigilant for neurological disease.
Possible causes include:
A thorough history should always precede treatment.
Bell’s palsy provides an excellent illustration of why practitioners should assess movement rather than appearances.
During the acute phase, the affected side demonstrates reduced movement due to lower motor neurone dysfunction of the facial nerve.
As recovery occurs, many patients develop compensatory muscle activity and varying degrees of synkinesis, where intended movement in one muscle group is accompanied by involuntary contraction elsewhere. Examples include involuntary eye narrowing during smiling or excessive lower facial movement during blinking.
At first glance, practitioners may assume that the side demonstrating greater movement is the abnormal side because it appears more expressive.
However, careful assessment often reveals that this represents compensatory hyperactivity, while the opposite side remains relatively weak.
This distinction fundamentally changes treatment planning. The objective is not simply to inject the side that appears more active, but to understand which muscles are generating excessive movement and whether reducing that activity is likely to improve overall facial balance. In many patients with chronic facial palsy, treatment focuses on selectively reducing hyperactivity on the unaffected or compensating side while respecting residual function on the previously affected side. In patients with synkinesis, carefully targeted botulinum toxin may also be used to reduce involuntary co-contraction as part of a broader rehabilitation plan, often alongside specialist facial physiotherapy.
Bell’s palsy therefore illustrates an important principle that extends well beyond facial nerve disorders:
Always identify the muscles responsible for the imbalance before deciding where to inject.
Rushing assessment is one of the commonest causes of poor outcomes.
A structured examination should become routine.
Establish:
Clarify whether the asymmetry has always been present or has recently developed.
A new asymmetry warrants greater caution.
Avoid asking the patient to move immediately.
Instead, spend time observing:
Photographs are invaluable.
Ask the patient to perform individual movements slowly:
The aim is to isolate muscle groups rather than simply observe a smile.
Video recording often reveals asymmetries that are not appreciated in still photographs.
This is arguably the most important stage of assessment.
Ask yourself:
Which muscle is producing excessive movement?
Which muscle is relatively weak?
Which movement is actually bothering the patient?
These questions often reveal that the apparent asymmetry originates from a different muscle group than first suspected.
Perhaps the most important decision an aesthetic practitioner makes is deciding not to treat.
The vast majority of facial asymmetries encountered in aesthetic practice represent normal anatomical variation, age-related change or long-standing muscular imbalance. However, facial asymmetry may also be the presenting feature of significant neurological, infective or neoplastic disease. It is therefore essential that practitioners undertake a thorough medical history and examination before considering treatment with botulinum toxin.
Cosmetic treatment should never be used to mask an unexplained or newly developed neurological deficit.
Any patient describing facial asymmetry that has developed suddenly over hours or days requires careful assessment.
Although Bell’s palsy is the commonest cause of acute unilateral facial weakness, practitioners should remember that it is a diagnosis of exclusion. A patient presenting with acute facial weakness may instead be experiencing an acute cerebrovascular event or another neurological disorder requiring urgent medical assessment.
Questions to establish include:
Patients with a new facial weakness that has not been medically assessed should be referred appropriately before any aesthetic treatment is considered.
Botulinum toxin should not be considered in patients presenting with new facial asymmetry accompanied by other neurological symptoms.
Red flag symptoms include:
The presence of additional neurological signs should immediately raise suspicion for central nervous system pathology, including stroke, intracranial haemorrhage or space-occupying lesions.
Upper motor neurone facial weakness classically affects the contralateral lower face more than the forehead because the upper facial muscles receive bilateral corticobulbar innervation. However, forehead weakness is not always completely absent, particularly in larger cortical lesions, so this sign should be interpreted in the context of the overall neurological examination.
Patients occasionally report that one side of the face has become progressively weaker over weeks or months.
Unlike Bell’s palsy, which typically reaches maximal weakness within several days, gradually progressive facial weakness is concerning and requires further investigation.
Possible causes include:
Progressive weakness should never be assumed to represent simple muscular asymmetry.
While recurrent Bell’s palsy does occur, repeated episodes of facial nerve weakness warrant further investigation.
Alternative diagnoses include structural lesions affecting the facial nerve, autoimmune disease and other neurological disorders. A detailed history should establish whether previous episodes were formally diagnosed and whether imaging or specialist assessment has already been undertaken.
Although mild peri-auricular discomfort commonly precedes Bell’s palsy, significant facial pain should prompt consideration of alternative diagnoses.
Persistent severe pain may suggest:
Pain should never be dismissed as incidental.
Patients reporting ear pain, hearing loss, tinnitus, vertigo or a vesicular rash involving the ear canal or palate may have Ramsay Hunt syndrome caused by reactivation of varicella-zoster virus affecting the facial nerve.
Prompt medical assessment is essential as early antiviral treatment improves outcomes.
Previous facial trauma should always be explored.
Asymmetry may result from:
Understanding the underlying anatomical deficit is essential before attempting cosmetic correction.
Operations involving the parotid gland, temporal bone, facial skin or orthognathic surgery may alter facial nerve function or muscle mechanics.
Patients may present many years later with compensatory muscular overactivity rather than primary muscle weakness. Whenever possible, obtain details of previous surgery before planning treatment.
The presence of a parotid swelling, persistent facial lump or cervical lymphadenopathy should prompt medical investigation before cosmetic intervention.
Neoplasms involving the parotid gland are a recognised cause of facial nerve dysfunction.
Patients describing incomplete eyelid closure, persistent dry eye, excessive tearing or exposure symptoms require careful assessment.
Weakness of orbicularis oculi may compromise corneal protection, and additional weakening with botulinum toxin could increase the risk of exposure keratopathy.
Similarly, new-onset ptosis without previous treatment should prompt consideration of neurological causes such as oculomotor nerve palsy or myasthenia gravis.
Generalised fatigable weakness should never be attributed to simple facial asymmetry.
Features requiring medical assessment include:
These symptoms may indicate disorders such as myasthenia gravis or other neuromuscular conditions, for which botulinum toxin may be inappropriate.
Finally, practitioners should trust their clinical judgement.
If the patient’s history is inconsistent, if the examination findings do not fit an anatomical pattern, or if the cause of the asymmetry cannot be satisfactorily explained, cosmetic treatment should be deferred until an appropriate diagnosis has been established.
Aesthetic medicine should complement good medical practice, not replace it. Taking time to investigate an unexplained asymmetry protects both the patient and the practitioner and reflects the standard of care expected of medically trained injectors.
Once a practitioner understands how to distinguish structural asymmetry from movement asymmetry and adopts a systematic assessment process, treatment planning becomes considerably more logical.
In the next article, we will explore upper facial asymmetries in detail, examining the interplay between the frontalis, corrugator supercilii, procerus and orbicularis oculi muscles, and how selective modulation of muscle activity can restore balance while preserving natural expression.
One of the commonest mistakes when treating facial asymmetry is focusing on the side that looks abnormal rather than identifying which muscle is generating the imbalance.
A useful question throughout the consultation is:
“Which muscle is producing the excessive movement?”
The answer is not always the side that first catches your eye.
Some of the most informative moments occur before the formal assessment begins.
Observe the patient while:
Patients often recruit facial muscles differently during natural conversation compared with instructed movements. Lower facial asymmetries involving the depressor labii inferioris (DLI) or depressor anguli oris (DAO) may be almost imperceptible when a patient is asked to “smile”, yet become immediately obvious during spontaneous speech.
Still photographs capture anatomy.
Video captures function.
A short recording of the patient talking, smiling naturally, laughing and counting aloud can reveal dynamic asymmetries that are impossible to appreciate in static images alone.
Where appropriate and with informed consent, video documentation can also provide a valuable baseline when reviewing treatment outcomes.
Greater movement does not necessarily indicate a stronger or healthier side.
Following facial nerve injury, surgery or longstanding weakness, the contralateral muscles often become relatively overactive in an attempt to restore facial expression. Conversely, muscles on the affected side may demonstrate synkinesis or inappropriate co-contraction during recovery.
Always determine whether the apparent asymmetry reflects:
Treatment planning differs considerably for each scenario.
Assess the patient at rest before asking them to move.
Ask yourself:
This distinction helps determine whether botulinum toxin is likely to improve the patient’s concern or whether another treatment modality may be more appropriate.
Rather than asking the patient simply to “smile”, isolate individual movements.
For example:
Breaking facial movement down into individual components makes it much easier to identify the muscles responsible for the asymmetry.
Facial muscles rarely work in isolation.
Every movement reflects the balance between agonists, antagonists and synergists. Weakening one muscle inevitably alters the forces acting on neighbouring muscles, sometimes in unexpected ways.
Before planning treatment, consider:
This approach reduces the risk of overcorrection and secondary asymmetry.
Many patients arrive expecting perfect symmetry.
Part of the consultation should involve explaining that facial asymmetry is normal and that the goal of treatment is improved balance rather than absolute symmetry.
Using a mirror or annotated photographs to demonstrate pre-existing asymmetry can help patients appreciate findings they had not previously noticed and promotes realistic treatment goals.
When correcting asymmetry, conservative treatment is generally preferable to attempting complete correction at the first session.
Facial muscles respond differently between individuals, and small changes in muscle activity can have a disproportionate effect on facial expression.
Under-correction is usually easier to refine at review than over-correction.
Assessment should not end once treatment has been administered.
A structured review allows the practitioner to evaluate:
Patients should understand that correcting dynamic asymmetry is often an iterative process rather than a single treatment event.
Perhaps the most useful habit an injector can develop is to pause before deciding where to inject and ask one final question:
“If I reduce the activity of this muscle, will facial movement become more balanced – or less?”
If the answer is uncertain, further assessment is usually more valuable than additional toxin.
This article was written by a guest contributor from our community. The views and clinical opinions expressed here belong to the author and do not necessarily reflect the opinions or endorsements of Dr Tim Ltd.
Dr Tim Pearce MBChB BSc (Hons) MRCGP founded his eLearning concept in 2016 in order to provide readily accessible BOTOX® and dermal filler online courses for fellow Medical Aesthetics practitioners. His objective was to raise standards within the industry – a principle which remains just as relevant today.
Our exclusive video-led courses are designed to build confidence, knowledge and technique at every stage, working from foundation level to advanced treatments and management of complications.
Thousands of delegates have benefited from the courses and we’re highly rated on Trustpilot. For more information or to discuss which course is right for you, please get in touch with our friendly team.
Bestseller
September 10, 2026
Bestseller
September 8, 2026
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |